Osteoporosis in anorexia nervosa
Conditions
Interventions
Trade Name: VItamin D
Product Name: D-vitamin olja
Product Code: A11CC
Pharmaceutical Form: Oral drops
Trade Name: Calcichew-D3
Product Name: Calcichew-D3
Pharmaceutical Form: Coated tablet
Sponsors
Kalmar County Council
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Females (>=18 years) fullfilling the criteria of anorexia and willing to participate in the study Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 200 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Treatment with litium, bisfosfonates, antiepileptics, cortison, disease with a risk of developing hypercalcemia, hypercalciuria, kidneystones. A vitamin D conentration > 100 nmol/L or an estimated GFR < 40 ml/min.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): Bonemarkers and bone density;Timepoint(s) of evaluation of this end point: Baseline, at 12 and 24 months (+ bonemarkers at 6 months). | — |
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To determine wether it is with vitamin D treament is possible to normalise bonemetabolism and density in female anorextic patients.;Secondary Objective: To study what doses of vitamin D is necessary in order to adequetly increase concentrations of vitamin D in female anorextic patients.;Primary end point(s): Vitamin D concentration;Timepoint(s) of evaluation of this end point: Baseline and every three months (every month during first three months) | — |
Countries
Sweden
Contacts
Public ContactPär Wanby
Kalmar County Council
Outcome results
None listed